Regulatory & Standards Task Force

Mission

 

The mission of the Digital Pathology Association Regulatory and Standards Task Force is to advance digital pathology by bringing clarity to the regulatory pathway for digital pathology including its evolution and creating awareness thereof, and working towards the development and adoption of standards as well as promoting interoperability in digital pathology for clinical use.

 

Participation in this Task Force is open to Benefactor member representatives only.

DPA’s comments on Federal RN for having certain medical devices exempt (click to read the full comment letter)

 

Making Permanent Regulatory Flexibilities Provided During the COVID–19 Public Health Emergency by Exempting Certain Medical Devices From Premarket Notification Requirements | Click HERE to access the federal register 

Task Force Members

 

Co-Chairs: Laura Chang & John Groth

 

  • Esther Abels, MSc, SolarisRTC LLC
  • Pinky Bautista, Bristol-Myers Squibb
  • Scott Blakely, Hamamatsu Corporation
  • Nathan Buchbinder, Proscia Inc.
  • Marilyn Bui, MD, PhD, Moffitt Cancer Center
  • Ian Cadieux, Proscia Inc.
  • Laura Chang, PhD, Artera
  • Chhavi Chauhan, MS, PhD, ELS, American Society for Investigative Pathology
  • Stephanie Cheng, PathAI
  • Cheng Cui, AstraZeneca
  • Bryce Dzialo, Hologic, Inc.
  • Eric Glassy, MD, Affiliated Pathologists Medical Group, Inc.
  • John Groth, MD, Endeavor Health
  • Thaddeus Hart, Leica Biosystems
  • Markus Herrmann, MD, PhD, Roche
  • Mufaddal Jafferji, Paige
  • Staci Kearney, PhD, RAC, Elevation Strategic Development, LLC
  • Grace Lee, Agilent Technologies
  • Eunice Lee, Agilent Technologies
  • Yael Liebes Peer, Ibex Medical Analytics
  • Tamatha Melton, Leica Biosystems
  • Eric Merchant, MS, NorthShore - Edward Elmhurst Health
  • Handy Oen, MBA, CT, MB (ASCP), Memorial Sloan Kettering Cancer Center
  • Anil Parwani, MD, PhD, MBA, Ohio State University Wexner Medical Center
  • Michael Quick, CT(ASCP), Hologic, Inc.
  • Jennifer Samboy, MHA, Philips
  • Patricia van Doornmalen, Philips
  • Jian Wang, AstraZeneca
  • Thomas Westerling-Bui, PhD, Aiforia
  • Zachary Wilczynski, Artera
  • David Witt, Bristol-Myers Squibb